MIRCERA is a prescription medication containing methoxy polyethylene glycol-epoetin beta, a type of erythropoiesis-stimulating agent (ESA). ESAs are medications that mimic the action of a natural hormone called erythropoietin, which stimulates the production of red blood cells in the bone marrow. MIRCERA is used to treat anemia associated with chronic kidney disease in adult patients. It is also used to treat anemia in adult cancer patients receiving chemotherapy.
Additional Information:
- Active Ingredient: Methoxy polyethylene glycol-epoetin beta.
- Dosage and Administration: MIRCERA is administered as a subcutaneous injection. The dose and frequency of administration will be determined by your doctor based on your individual needs.
- Side Effects: Common side effects of MIRCERA include headache, nausea, vomiting, diarrhea, and injection site reactions. Serious side effects can include high blood pressure, heart attack, stroke, and blood clots.
- Precautions: MIRCERA should not be used in patients with uncontrolled hypertension or a history of serious cardiovascular events. It should also be used with caution in patients with a history of seizures or other neurological disorders.
Storage:
- Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
- Do not freeze.
- Keep the vial in the outer carton to protect from light.
Manufacturer:
Roche
Note:
This product requires a prescription and should be used under the supervision of a qualified healthcare professional.
Disclaimer: The information provided here is for educational purposes only and should not replace professional medical advice. Always consult with a healthcare provider for medical guidance.
Reviews
There are no reviews yet.